Bevacizumab, Everolimus (RAD001), and Lapatinib as Neoadjuvant Chemotherapy Regimes for Primary Breast Cancer (GeparQuinto)

Clinical Trial ID NCT00567554

PubWeight™ 28.46^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00567554

Top papers